World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
29995
World Ranking
16465
National Ranking
537

Overview

Ahmed Idbaih is affiliated with Sorbonne University in France and has a substantial body of research primarily centered on oncology, genetics, and molecular biology. Their work covers a broad spectrum of topics related to brain tumors and cancer diagnostics, with a particular emphasis on gliomas and glioblastoma.

Idbaih's recent publications include:

  • Mechanisms and therapeutic implications of hypermutation in gliomas, 2020, Nature
  • Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter, 2022, Neuro-Oncology
  • Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial, 2022, Neuro-Oncology
  • Challenges in glioblastoma research: focus on the tumor microenvironment, 2022, Trends in cancer
  • Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives, 2020, Cancers

The frequent co-authors collaborating with Idbaih include:

  • Franck Bielle
  • Maïté Verreault
  • Mehdi Touat
  • Marc Sanson
  • Khê Hoang-Xuan

Idbaih's publications have appeared repeatedly in several key scientific venues, which include:

  • Neuro-Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancers
  • European Journal of Cancer
  • Journal of Clinical Oncology

The main fields of study for Idbaih's research are:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

The subfields of study frequently addressed are:

  • Genetics
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Oncology
  • Cancer Research

The major topics covered in their work include:

  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Histiocytic Disorders and Treatments
  • Cancer Genomics and Diagnostics
  • Meningioma and schwannoma management
  • Cancer Immunotherapy and Biomarkers
  • Cancer, Hypoxia, and Metabolism

Best Publications

  • Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial

    Roger Stupp;Roger Stupp;Roger Stupp;Sophie Taillibert;Sophie Taillibert;Andrew Kanner;William Read;William Read

  • Maintenance therapy with tumor-Treating fields plus temozolomide vs temozolomide alone for glioblastoma a randomized clinical trial

    Roger Stupp;Roger Stupp;Sophie Taillibert;Andrew A. Kanner;Santosh Kesari

  • Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas

    Marc Sanson;Yannick Marie;Sophie Paris;Ahmed Idbaih

  • Primary brain tumours in adults

    Anthony Behin;Khe Hoang-Xuan;Antoine F Carpentier;Jean-Yves Delattre

  • Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

    Roger Stupp;Roger Stupp;Roger Stupp;Sophie Taillibert;Sophie Taillibert;Andrew Kanner;William Read;William Read

  • Genome-wide association study identifies five susceptibility loci for glioma

    Sanjay Shete;Fay J. Hosking;Lindsay B. Robertson;Sara E. Dobbins

  • Lomustine and Bevacizumab in Progressive Glioblastoma

    Wolfgang Wick;Thierry Gorlia;Martin Bendszus;Martin Taphoorn

  • Clinical trial of blood-brain barrier disruption by pulsed ultrasound

    Alexandre Carpentier;Michael Canney;Alexandre Vignot;Vincent Reina

  • Mechanisms and therapeutic implications of hypermutation in gliomas.

    Mehdi Touat;Mehdi Touat;Mehdi Touat;Yvonne Y. Li;Yvonne Y. Li;Adam N. Boynton;Adam N. Boynton;Liam F. Spurr;Liam F. Spurr

  • IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas

    C. Houillier;X. Wang;G. Kaloshi;K. Mokhtari

  • A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry.

    Soufiane El Hallani;Blandine Boisselier;Florent Peglion;Audrey Rousseau

  • Glioblastoma targeted therapy: updated approaches from recent biological insights

    M. Touat;M. Touat;A. Idbaih;M. Sanson;K.L. Ligon

  • IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

    Martin J. van den Bent;Hendrikus J. Dubbink;Yannick Marie;Alba A. Brandes

  • Safety and Feasibility of Repeated and Transient Blood-Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma.

    Ahmed Idbaih;Michael Canney;Lisa Belin;Carole Desseaux

  • MRI of Clot in Cerebral Venous Thrombosis: High Diagnostic Value of Susceptibility-Weighted Images

    Ahmed Idbaih;Monique Boukobza;Isabelle Crassard;Raphaël Porcher

  • Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester Disease

    Julien Haroche;Fleur Cohen-Aubart;Jean-François Emile;Philippe Maksud

  • Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors

    Beatrice S Melin;Jill S Barnholtz-Sloan;Margaret R Wrensch;Christoffer Johansen

  • Temozolomide for low-grade gliomas: Predictive impact of 1p/19q loss on response and outcome

    G. Kaloshi;A. Benouaich-Amiel;F. Diakite;S. Taillibert

  • All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2

    M. Labussière;A. Idbaih;X.-W. Wang;Y. Marie

  • Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas

    Alberto Gonzalez-Aguilar;Ahmed Idbaih;Blandine Boisselier;Naima Habbita

Frequent Co-Authors

Marc Sanson
Marc Sanson Sorbonne University
Khê Hoang-Xuan
Khê Hoang-Xuan Université Paris Cité
Jean-Yves Delattre
Jean-Yves Delattre Université Paris Cité
Martin J. van den Bent
Martin J. van den Bent Erasmus University Rotterdam
Dominique Figarella-Branger
Dominique Figarella-Branger Aix-Marseille University
Roger Stupp
Roger Stupp Northwestern University
Pieter Wesseling
Pieter Wesseling University of Amsterdam
Keith L. Ligon
Keith L. Ligon Harvard University
Johan M. Kros
Johan M. Kros Erasmus University Rotterdam
Olivier Delattre
Olivier Delattre PSL University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine extends beyond the classroom, with a growing number of students turning to online degrees in healthcare. These pathways offer flexibility, affordability, and opportunities for career advancement. Whether you’re just beginning your nursing journey or seeking to specialize, there are diverse programs available.

For those looking to become a Family Nurse Practitioner, several universities now offer the cheapest fnp programs online, combining quality education with cost savings. If you’re aiming for higher-level nursing roles, the cheapest online msn programs make earning a Master of Science in Nursing accessible for more students.

Those interested in advanced research or teaching might explore the online phd nursing options, which allow for continued professional development while working. Additionally, registered nurses hoping to obtain a bachelor’s degree can find the cheapest bsn programs to help advance their credentials.

Online healthcare degrees offer accessible, flexible routes into key medical roles that are always in demand. Carefully compare program costs and accreditation to ensure the right fit for your career goals.

Best Scientists Citing Ahmed Idbaih

Trending Scientists